Signal detail

News insight

Source-backed analysis, the reasoning behind the signal, and its market context.

Back to signals Ask the Agent

DCHBullishEarningsShort Term

High materiality7/10

Dauch Reports Second Quarter 2026 Financial Results

StockNews.AIAug 7, 8:00 AM EDT1 source

Trading thesisImportance 7/10

Go long DCH on expected Dowlais synergy realization and cash-flow expansion within the next 6–12 months.

AI summary

What happened and why it matters

Dauch Corporation reported Q2 2026 sales of $2.96B and Adjusted EBITDA of $389.6M (13.2% margin), driven by the Dowlais acquisition. Net income was $1.0M, while operating cash flow reached $107.5M and Adjusted free cash flow $148.4M, underscoring improved cash generation amid the post-acquisition integration. The company raised its 2026 targets, highlighting synergy benefits and a partial-year Dowlais contribution, which could support a re-rating if execution meets plan within 6–12 months.

Dowlais completion in Feb 2026 provides material uplift to run-rate synergies.
2026 guidance updated: synergy benefits of $60–$75M and >$100M run rate by year one.
China JV equity income now included in Adjusted EBITDA: $70–$80M.
Free cash flow framework supports potential deleveraging or capital deployment.

Sentiment rationale

The company delivered sizable cash flow (operating CF $107.5M; adjusted FCF $148.4M) and raised 2026 targets, with Dowlais synergy and China JV benefits baked in. If Dowlais synergy delivers as modeled (run-rate >$100M by year one) and the China JV contribution materializes, investors may reprice DCH higher on improved cash flow and visibility. Historical parallels: when post-acquisition synergies unlocks material cash flow, shares tend to re-rate on confidence in the integration trajectory, despite near-term earnings volatility.

Key facts

01
Q2 2026 sales $2.96B; net income attributable to Dauch $1.0M. Dowlais integration boosts results.
02
Adjusted EBITDA $389.6M (13.2% of sales); Adjusted EPS $0.32; Diluted EPS $0.00.
03
Operating cash flow $107.5M; Adjusted free cash flow $148.4M; strong cash generation.
04
Updated 2026 outlook: Sales $10.6-10.8B; Adjusted EBITDA $1.36-1.425B; synergy $60-75M; China JV $70-80M.
05
Dowlais completion Feb 3, 2026; partial-year contribution; segment reporting reorganized to reflect Dowlais.

Earnings

Category: Earnings. This is a structured earnings release detailing quarterly results, updated full-year guidance, and the financial impact of a post-M Dowlais acquisition, aligning with a corporate earnings narrative focused on cash flow, margins, and synergy-driven growth.